Further characterization of endogenous signals that activate this enhancer and small molecules or genetic activation of E1 may provide new opportunities to increase TTN expression levels and overcome the deleterious effects of TTNtv that cause DCM and cardiac arrhythmias. This evidence concerns the gene TTN and cardiac rhythm disease.